Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/gme.0000000000001080
PubMed Identifier: 29462094
Publication URI: http://europepmc.org/abstract/MED/29462094
Type: Journal Article/Review
Volume: 25
Parent Publication: Menopause (New York, N.Y.)
Issue: 7
ISSN: 1072-3714